placeholder image

MR Andrew Ellis

Positions

  • Therapeutic Drug Monitoring and Pharmacokinetics

Overview

OverviewText1

  • Andrew Ellis obtained his undergraduate and postgraduate qualifications at the University of Melbourne has been an honorary Research Fellow with the Department of Medicine University of Melbourne and Senior Scientist in Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg Victoria since 2004.

    He possesses extensive experience in the quantitation of drug/hormone/biomarkers in biological matrices and manages the Clinical Pharmacology and Therapeutics laboratory that has a long history of basic and clinical neuroscience research and of providing accredited pathology services analysing biogenic amines and therapeutic drug monitoring test services. Andrew has a background in chemotherapy clinical trial research and specialises in chromatography- and mass spectrometry-based analysis and pharmacokinetics. He is currently actively involved in a variety of local and national collaborative clinical research studies and is a member of the Steering Committee for ‘Autonomic Effects in Spinal Cord Injury’, and a member of the Executive Group for ‘the eGFR Study: Accurate Assessment of Renal Function in Indigenous Australians’.  In addition Andrew is experienced in: stability testing procedures for pharmaceutical formulations, the development of tailored methods for analysis of new and established drugs in biological samples, and clinical trial and accredited laboratory protocol preparation and regulatory guideline adherence. 

       

Affiliation

Member of

  • Australian Association of Clinical Biochemists. Associate member 2006 -
  • Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Member 1996 -

Publications

Selected publications

Research

Additional Grant Information

  • Grant funding toward establishing Tandem Mass Spectrometry Capability to support biomedical research at the Austin Health precinct, 2009: 
    §The Austin Health and Medical Research Foundation $10k
    § The University of Melbourne Faculty of Medicine, Dentistry and Health Sciences Equipment grant $75k 
    § The Victorian Neurotrauma Initiative (VNI) – ANS in Spinal Cord Injury grant $20k
    § The Ian Potter Foundation $100k
    § The Ramaciotti Foundation $50k
    § The Collie Foundation $50k
    § The Urqhart Foundation $50k
    Austin Health Medical Research Foundation. Stability of a capsule formulation of N-acetylcysteine for use in the prevention of contrast-induced nephropathy. 2005/6 $10k.
    SHPA (Society of hospital Pharmacists of Australia) DBL Development Fund. Stability of flucloxacillin in hospital in the home (determining the stability of flucloxacillin as used in hospital in the home) 2008 $10k
    SHPA (Society of hospital Pharmacists of Australia). Stability, safety and suitability of prefilled metaraminol syringes – Roche Research Grant on quality and Safety 2010 $10k
     

       

Awards

Education and training

  • GradDipIT, Royal Melbourne Institute of Technology 2003
  • MSc, University of Melbourne 1983
  • BSc (hons), University of Melbourne 1980

Linkages